BIOSIMULYTICS
BioSimulytics develops AI-powered software for drug researchers.
BIOSIMULYTICS
Social Links:
Industry:
Artificial Intelligence Machine Learning Pharmaceutical Software
Founded:
2019-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.biosimulytics.ai
Total Employee:
1+
Status:
Active
Total Funding:
595 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Global Site Tag Amazon Google Apps For Business Cloudflare JS
Similar Organizations
35up
Bringing Embedded Cross-Selling into every online checkout.
Mimica Automation
Mimica watches you work and learns to automate your most repetitive tasks.
Pera Labs
Pera Labs develops digiceuticals and AI-powered solutions for fertility.
Current Employees Featured
Founder
Investors List
Enterprise Ireland
Enterprise Ireland investment in Seed Round - BioSimulytics
Official Site Inspections
http://www.biosimulytics.ai
- Host name: 199.60.103.196
- IP address: 199.60.103.196
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "BioSimulytics"
BioSimulytics - AI-enhanced molecular modelling
Boosting success rates in Pharma R&D through the predictive power of AI-enhanced molecular modelling. BioSimulytics has developed breakthrough technology combining quantum physics, computational chemistry, machine …See details»
BioSimulytics - Crunchbase Company Profile & Funding
BioSimulytics develops AI-powered software for drug researchers. M2M-CSP: A solution for predicting crystal structures, enhancing speed and certainty in identifying stable crystal …See details»
biosimulytics - LinkedIn
Biosimulytics is a deep-tech spin-out from University College Dublin’s School of Chemical & Bioprocess Engineering, founded in 2019. We specialize in leveraging cutting-edge AI, advanced neural ...See details»
BioSimulytics 2025 Company Profile: Valuation, Funding
BioSimulytics General Information Description. Developer of an AI-enhanced predictive platform designed to assist pharmaceuticals with the development of drugs. The company's platform …See details»
Biosimulytics - Company Profile
BioSim Services accelerates pharmaceutical R&D by using AI-enhanced molecular modeling to predict drug molecule behavior and boost success rates. ... Toggle menu. Biosimulytics. …See details»
BioSimulytics Overview | SignalHire Company Profile
BioSimulytics Limited is a spin-out company founded in 2019 from the School of Chemical & Bioprocess Engineering of University College Dublin (UCD) in Ireland. ... The company is …See details»
Biosimulytics | EIT
Biosimulytics (Ireland), is developing a quantum physics-based, AI/ML-powered pharmatech platform to improve the speed, scale, novelty and success rate of drug development.The company has received tremendous support through …See details»
BioSimulytics Secures €595k in Seed Funding - University College …
Sep 2, 2021 BioSimulytics Secures €595k in Seed Funding - UCD spin-out has developed a novel software solution using artificial intelligence to transform the success rates of new drug …See details»
UCD spin-out company secures €595k in seed funding to advance …
Sep 2, 2021 BioSimulytics (www.biosimulytics.ai), a University College Dublin (UCD) spin-out company, today announced that it has secured €595k in initial seed funding from a number of …See details»
BioSimulytics Reviews, Funding, Founder, Valuation & Jobs
Find out if BioSimulytics is hiring now! Explore jobs, salary, equity, funding, founder, and valuationn information. Read about work-life balance, perks, benefits, and the company …See details»
Next-generation digital platform for faster, more accurate and …
BioSimulytics provides a unique software solution using neural network technology and high performance computing for the accurate prediction of crystal structures of new drug molecules …See details»
BioSimulytics - 2025 Company Profile - Tracxn
Feb 25, 2025 BioSimulytics - Provides AI-enhanced molecular modelling platform for biopharma sector. Raised a total funding of $709K over 3 rounds from 3 investors. Founded by Peter F …See details»
BioSimulytics - Funding, Financials, Valuation & Investors
BioSimulytics develops AI-powered software for drug researchers. New. Resources. Advanced Search. Start Free Trial . ... How much funding has this organization raised over time? Show . …See details»
BioSimulytics - EU-Startups
BioSimulytics was formed in November 2019 as a spin-out company from the School of Chemical and Bioprocess Engineering at University College Dublin (UCD), Ireland. The company is …See details»
Biosimulytics Secures European Innovation Council Accelerator …
Jun 21, 2023 The Biosimulytics platform, which combines AI neural networks, quantum physics and high-performance computing technologies to accurately simulate and predict the crystal …See details»
Charting a Course for Ethical AI Implementation: Q&A
1 day ago Responsible implementation has become a critical priority as artificial intelligence reshapes enterprise operations, informed by the evolving regulatory landscape. In this Q&A, …See details»
BioSimulytics - Updates, News, Events, Signals & Triggers
Organization. BioSimulytics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Growth Insight Details. Powered by AI . Edit Growth …See details»
5 practical steps for implementing responsible AI - HCLTech
Apr 9, 2025 3. Monitoring and managing AI risks: Shadow AI and beyond. A critical aspect of Responsible AI is addressing the risks of “shadow AI,” where teams or individuals use AI tools …See details»
BioSimulytics - Crunchbase
BioSimulytics develops AI-powered software for drug researchers.See details»
Microsoft: G7 Hiroshima AI Process (HAIP) Transparency Report
Apr 22, 2025 At Microsoft, tactics we use to identify and prioritize AI risks include threat modeling, responsible AI impact assessments, customer feedback, incident response and …See details»